Enhances health care market oversight and pharmaceutical access in Massachusetts.
This bill aims to strengthen oversight of the health care market and improve access to pharmaceuticals in Massachusetts. It includes provisions for penalties against provider organizations that fail to provide requested information, limits on cost-sharing for certain drugs and devices, and requirements for pharmaceutical companies to notify the commission of price increases.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.